Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03000231 · ClinicalTrials.gov registry record
Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 86
- Enrollment target
NCT03000231 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 86 participants.
The verdict
NCT03000231 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
The purpose of this study is to compare cardio-metabolic risk, glucose tolerance, and night time blood pressure between healthy control subjects and patients with adrenal insufficiency. No intervention will be administered and the study is observational only.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2015-10 |
| Est. Completion | 2023-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03000231
The ClinicalTrials.gov registry entry for NCT03000231 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03000231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03000231 about?
NCT03000231 is a clinical study titled "Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency". The purpose of this study is to compare cardio-metabolic risk, glucose tolerance, and night time blood pressure between healthy control subjects and patients with adrenal insufficiency. No intervention will be administered and the study is observational only.
What is the current status of trial NCT03000231?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2015-10. Estimated completion is 2023-12.
Who is sponsoring clinical trial NCT03000231?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.